{"id":"W2166594813","doi":"10.1158/1078-0432.ccr-13-1869","title":"Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Marsden Fund; Pfizer; Prostate Cancer Foundation","keywords":"Medicine; Docetaxel; Prostate cancer; Clinical endpoint; Internal medicine; Adverse effect; Prednisone; Urology; Phases of clinical research; Oncology; Chemotherapy; Cancer; Randomized controlled trial; Surgery; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005600736,0.0003117931,0.001748575,0.0002630774,0.0004871986,0.0001017596,0.0002200728,0.0001034929,0.0002198402],"category_scores_gemma":[0.001388649,0.0001901062,0.0002147567,0.0005774335,0.001663124,0.0001761309,0.0001660303,0.0007057824,0.000003033004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002413776,"about_ca_system_score_gemma":0.001761835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003374436,"about_ca_topic_score_gemma":0.002099833,"domain_scores_codex":[0.9949203,0.0008399218,0.001166558,0.0008603705,0.001382324,0.0008305453],"domain_scores_gemma":[0.9943169,0.002652819,0.0002955293,0.0005938513,0.001627518,0.0005134306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9515752,0.009695532,0.003157112,0.001445508,0.002499581,0.00009357027,0.002384717,0.00008992777,0.001724497,0.0001416197,0.007239298,0.01995343],"study_design_scores_gemma":[0.9513122,0.03326397,0.002086041,0.000540169,0.001048665,0.000008831468,0.000939734,0.002151924,0.002019036,0.0004817205,0.005824029,0.00032372],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836788,0.003145446,0.00005886298,0.002119999,0.0001070845,0.008891455,0.001814333,0.0000274763,0.0001565465],"genre_scores_gemma":[0.9893479,0.00196415,0.0002925413,0.0000986145,0.0002312008,0.004808882,0.0002279419,0.00005148213,0.002977225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02356844,"threshold_uncertainty_score":0.7752308,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.213024909223242,"score_gpt":0.5482458703631305,"score_spread":0.3352209611398885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}